Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 06. March 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8823  Previews Next
   
   Articles 1 - 20 / 176460  
   
Multi-omics analysis suggests ZDHHC18 as a potential risk factor for clear cell renal cell carcinoma linked to myeloid DC morphology.
Discov Oncol
Guo A, Lu Y, Wang J, Jia Z, Yang J, Ning X.
PMID: 41790354 [PubMed - as supplied by publisher]


Assessment of radiotherapy effect and toxicity using tissue-associated DNA methylation markers in cell-free DNA: a study on prostate cancer.
Radiat Environ Biophys
Bahtiyar N, Mermut O, Firtina S, Ozaydin A, Suleymanova A, Isikgil B, Onaran .
PMID: 41790195 [PubMed - as supplied by publisher]


Study on the prediction of postoperative metastasis in renal cancer using perirenal fat CT radiomics combined with clinical features.
Front Oncol
Zhou J, Zhou T, Yang Y, Zhang C, Ma Y, Xu J.
PMID: 41788995 [PubMed]


Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study.
Front Oncol
Pantano F, Malgeri A, De Giorgi U, Maruzzo M, Fornarini G, Zucali P, Fratino L, Milella M, Pedrazzoli P, Procopio G, Stellato M, Naglieri E, Soto Parra H, Napoli MD, Mollica V, Tudini M, Pipitone S, Santoni M, Ricotta R, Banna GL, Catalano F, Cavo A, Vignani F, Masini C, Casadei C, Galli L, Nolè F, Sorarù M, Prati V, Panni S, Roviello G, Prati G, Morelli F, Messina C, Atzori F, Rescigno P, Santini D, Buti S, Rebuzzi SE.
PMID: 41788982 [PubMed]


A phase I study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): dose escalation results.
Cancer Res Commun
Talmor B, Marastoni S, Lau B, Yam AO, Yeung N, Lin HM, Li ZJ, Woo H, Pranavan G, Stricker PD, Horvath LG, Koritzinsky M, Wouters BG, Crumbaker M, Joshua AM.
PMID: 41788020 [PubMed - as supplied by publisher]


Diagnostic accuracy of (68)Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
Sci Prog
Qin Z, Pan G, Huang W, Xu L, Jia R.
PMID: 41787866 [PubMed - in process]


Multifocal cohort analysis unveils cell types associated with regional lymph node seeding in prostate cancer.
Genome Med
de Schaetzen van Brienen L, Jung T, Larmuseau M, Van der Eecken K, Van Hecke M, Haerinck J, De Coninck J, Vanwelkenhuyzen J, Lumen N, De Laere B, De Witte N, Miclotte G, Verbeke S, Berx G, Van Dorpe J, Ost P, Marchal K.
PMID: 41787470 [PubMed - as supplied by publisher]


Exercise and Phellodendron amurense extract differentially impinge on oxidative stress response pathways in a mouse model of prostate cancer.
Sci Rep
Patel DI, Rivas P, Chen Y, Lai Z, Ikeno Y, Kumar AP, Ghosh R.
PMID: 41787055 [PubMed - as supplied by publisher]


Glycoprotein biomarkers for bladder cancer detection.
Clin Chim Acta
Khan A, Alanazi FJ, Ahmed S, Alzahrani AR, Rehman ZU, Ali YH, Saeed IK, Siddique MI.
PMID: 41786262 [PubMed - as supplied by publisher]


Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial.
Ann Oncol
Choueiri TK, Albigès L, McDermott DF, Hammers HJ, Escudier B, Burotto M, Plimack ER, Porta C, George S, Powles T, Donskov F, Atkins MB, Gurney H, Kollmannsberger CK, Grimm MO, Barrios C, Castellano D, Grünwald V, Tomita Y, Rini BI, Jiang R, van Kooten Losio M, Lee CW, Tannir NM, Motzer RJ.
PMID: 41786248 [PubMed - as supplied by publisher]


Real-World Data on Neoadjuvant Chemotherapy for Localized Muscle-Invasive Bladder Cancer (2015-2024): A Single-Center Retrospective Study.
Fr J Urol
Tanguy M, Armelle P, Sheik E, Nicolas I, Caroline C, Simon B, Mikael AA, Maxime V, Stessy K.
PMID: 41786089 [PubMed - as supplied by publisher]


Comparison of prostate cancer detection rates between micro-ultrasound-guided and multiparametric magnetic resonance imaging-guided prostate biopsy: A systematic review and meta-analysis of prospective studies.
Urol Oncol
Lu Y, Zhao D, Han Y, Guo Y, Dong Y.
PMID: 41785618 [PubMed - as supplied by publisher]


ICG fluorescence imaging in sentinel lymph node identification: toward a standardized protocol in paediatric renal tumour surgery.
Pediatr Surg Int
Wojtylko A, Garnier H, Rapala M, Murawski M, Kozakiewicz M, Jedrzejak E, Dachowska-Kalwak I, Pietras W, Czauderna P, Godzi.
PMID: 41784812 [PubMed - in process]


[(68)Ga]PSMA-11 PET/CT vs. mpMRI in patients with a high suspicion of prostate cancer and previous negative biopsy: head to head, parallel, prospective trial (PROSPET-BX).
Eur J Nucl Med Mol Imaging
Lopci E, Lazzeri M, Saita A, Saitta C, Disconzi L, Colombo P, Fasulo V, Tarullo G, Vuono E, Peschechera R, Zanca R, Jandric J, Sposta FM, Scapaticci E, Paciotti M, Hurle R, Benetti A, Avolio PP, Cieri M, Zandegiacomo S, Pasini L, Casale P, Guazzoni G, Balzarini L, Laghi A, Buffi NM, Lughezzani G.
PMID: 41784782 [PubMed - as supplied by publisher]


Immune checkpoint inhibitors in bladder cancer: from mechanistic insights to emerging combination frontlines.
Clin Exp Med
Ajalli MM, Sansebli Y, Ekrami D, Alaeenejad F, Abbasi A, Eini P, Hassanzadeh F, Bahrami N.
PMID: 41784671 [PubMed - as supplied by publisher]


The paradox of cellular senescence in prostate cancer: from tumor suppression to tumor promotion.
Front Oncol
Xing Y, Qin G, Lin X, Chen S, Su Y, Lin T, Chen G.
PMID: 41783438 [PubMed]


AMACR and ZFPL1 serum biomarkers enhance precision in predicting postoperative prostate cancer outcomes.
Front Oncol
Yang L, Lv R, Liu Z, Chen G, Gu G.
PMID: 41783436 [PubMed]


Correction to 'Quercetin Can Be a More Reliable Treatment for Metastatic Prostate Cancer Than the Localized Disease: An In Vitro Study'.
J Cell Mol Med

PMID: 41782225 [PubMed - in process]


Prostate-specific antigen testing and prostate cancer-related outcomes: a Danish nationwide study.
BJU Int
Palshof FK, Mørch LS, Brasso K, Kroman N, Larsen SB, Røder A, Stroomberg HV.
PMID: 41782199 [PubMed - as supplied by publisher]


Changes in perceived cognitive functioning following a codesigned online group cognitive rehabilitation for prostate cancer survivors on androgen deprivation therapy: Series of single-case experimental designs.
Neuropsychol Rehabil
Pembroke L, Sherman KA, Dhillon HM, Francis H, Gillatt D, Gurney H.
PMID: 41781343 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 176460    Page 1 of 8823  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1